The effectiveness of Modified Mindfulness-based Cognitive Therapy for hospitalized Children Hospitalized with Cancer compared to control group in attention problems and internalizing problems.

aurentian Universiry0 个研究点目标入组 40 人开始时间: 待定最近更新: 2021年2月22日

适应症

试验速览

暂无简介。

•Hospitalized patients were eligible to participate in the Mindfulness-Based Cognitive Therapy for Children (MBCT-C) program in addition to receiving TAU if they were (a) 11 to 13 years of age; (b) had at least average fluency in Persian; (c) had received the first diagnosis of any type of cancer except brain cancers; (d) were undergoing radiation therapy and/or chemotherapy through the hospital’s oncology division; and (e) had not received any psychological interventions or psychiatric medications in the six months preceding the study. Diagnostic inclusion criteria were: (f) a diagnosis of Autism spectrum disorder (ASD) (Diagnostic and Statistical Manual of Mental Disorders (IV) (DSM-IV (American Psychiatric Association, 2000); and (g) at least two comorbid diagnoses in any of four diagnostic categories (anxiety, depression, psychosomatic, or attention deficit disorders). Diagnoses were ascertained using the Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Persian version (K-SADS-PL-P). Additionally, patients needed to be: (h) in the borderline or clinical range for internalizing problems (T-score = 60) and attention problems (T-score = 57) on at least two of four subscales of the Child Behavior Checklist (CBCL) or Youth Self-Report (YSR )(depression/anxiety, withdrawal/depression, somatic complaints, and attention problems) at the screening assessment.

•Patients who were determined to (i) have a major cognitive dysfunction or developmental disability, or (j) was diagnosed with a terminal illness (defined as having a prognosis of fewer than six months) were excluded. Moreover, Brain cancers were excluded based on research suggesting that these may affect attention (Raghubar et al., 2017), a key outcome variable.

发起方

aurentian Universiry